Memorial Sloan Kettering neuro-oncologist Thomas Kaley

Areas of Expertise

Conditions I Treat

  • Primary brain tumors
  • Brain metastases
  • Central nervous system (CNS) lymphoma

My Specialties

  • Neuro-oncology
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a neuro-oncologist who specializes in the care of patients with brain tumors and the neurologic complications of cancer. My team of physicians, nurses, research staff, and administrative support works with patients to deliver effective and compassionate specialized care for adult primary brain tumors, including:

  • Glioblastomas
  • Gliomas (low-grade gliomas and anaplastic gliomas)
  • Meningioma
  • Ependymomas
  • Other rare tumors

I also treat brain metastases that have spread from other solid cancers in the body.

Read more

I am currently conducting clinical trials and research for glioblastomas and other primary brain tumors in both the upfront and recurrent settings. My research also focuses on the treatment of patients with both benign and aggressive meningiomas, specifically investigating chemotherapy and molecularly targeted therapy when surgery and radiation are not an option.

In addition to treating patients, I serve as Chief of the Neuro-Oncology and Cancer Neurology Service. I also serve as Vice Chair for Clinical Research in the Department of Neurology and the Chair of the Institutional Review Board (IRB-C), where I oversee departmental and institutional research portfolios at MSK. I also have a firm commitment to teaching and mentoring national and international neuro-oncology fellows, junior faculty, residents, and house staff.

What I Do at MSK

I'm a neuro-oncologist at MSK. This is a doctor with special training in cancers that affect the brain, spinal cord, peripheral nerves, and muscles. This includes brain tumors and central nervous system tumors.

I'm an early drug development specialist, which is a scientist who tests new drugs to treat cancer. I have special training in research studies, also known as clinical trials.

  • Chief, Neuro-Oncology and Cancer Neurology Service
  • Vice Chair for Clinical Research, Department of Neurology
  • Chair, Institutional Review Board (IRB-C)
Areas of Expertise

Conditions I Treat

  • Primary brain tumors
  • Brain metastases
  • Central nervous system (CNS) lymphoma
  • Neurologic complications of cancer
  • Gliomas
  • Meningiomas
  • Ependymoma

My Specialties

  • Neuro-oncology
Education & Honors

Education

  • MD, New York University

Residencies

  • Neurology - New York University School of Medicine

Fellowships

  • Neurology - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Neurology

Awards and Honors

  • Castle Connolly: America’s Top Doctor (2025)
  • Castle Connolly: America’s Top Doctor (2024)
  • Top Doctors New York Metro Area, Castle Connolly (2019-2023)
  • Castle Connolly: America's Top Doctors (2019-2023)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Dr. Kaley sees patients at two locations.

Office Phone
Location
New York, NY
West Harrison, NY
160 East 53rd Street New York NY 10022
500 Westchester Avenue West Harrison NY 10604

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Collaborators doctors

See all Early Drug Development Service doctors

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Kaley’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Thomas J. Kaley discloses the following relationships and financial interests:

  • Servier
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures